Voriconazole: A second-generation triazole
- P. H. Chandrasekar(corresponding author),
- E. Manavathu
- Wayne State University
Scholary Output:
Contribution to journal
Review article
Peer-reviewAbstract
Voriconazole, a derivative of fluconazole, is an antifungal triazole with expanded spectrum of activity against a variety of yeasts and filamentous fungi. It exhibits fungicidal activity against Aspergillus species. Preliminary data from animal models and clinical trials show promise in the treatment of candidiasis and aspergillosis. Of concern is the development of resistance to voriconazole and cross-resistance with other azoles. Voriconazole is a welcome addition to our limited armamentarium against potentially fatal fungal infections.
Publication Information
Output type
Scholary Output:
Contribution to journal
Review article
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 135-148 (14 pages)Journal (Volume, Issue Number)
Drugs of Today (Volume 37, Issue 2)Publication milestones
- Published - 2001
Publication status
Published - 2001
ISSN
1699-3993Publication IDs
- Scopus: 0035073834
Publication metrics
Metrics
SciVal
FWCI
3.05
SciVal
Author count
2
SciVal
citations
97
SciVal
Paper percentile
93
SciVal
Top percentile
10
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Captures
10
Citation count
101
